TyraTech granted two new US patents

Insecticide specialist TyraTech  has been granted two new patents for its pest control compositions by the US authorities.

The first patent covers a range of current and pipeline animal health products, including those that will be sold by Novartis Animal Health US for the control of flies, cockroaches and other insects in production animal facilities.

The patent, which has a 20-year term, also covers products sold into professional pest control by Envance Technologies, TyraTech’s joint venture with AMVAC Chemical Corporation.

The second patent covers the company’s Extend technology, which aims at increasing efficacy while reducing the environmental effects of synthetic pesticides.

It supports a number of TyraTech’s animal health pipeline products, as well as pipeline products from Envance Technologies.

The group now has 21 patents, with another 50 pending.

Chief executive Bruno Jactel said: “These new patents are a testimony to the quality and innovation behind TyraTech's technology and products. More importantly they will provide protection for TyraTech's products that are already in the market and for products that TyraTech is currently developing.

“Our research and development teams are continually working to develop new products and formulations that are patentable with the objective of strengthening our growth platform.”